Loss of unconjugated and secondary BAs could lead to a reduced activation of FXR and TGR5 and therefore a loss of anti-inflammatory actions and gut integrity protecting effects, which contributes to the pathogenesis of IBD [23]. This evidence concerns the gene NR1H4 and inflammatory bowel disease.